ACAD
31.91
+0.47
+1.49%
AEMD
1.5
+0.08
+5.6268%
APRI
1.514
+0.034
+2.2838%
ARNA
20.75
-0.27
-1.28%
ATEC
1.94
+0.02
+1.04%
CNAT
5.12
-0.06
-1.16%
CRXM
0.172
0.00
0.00%
CYTX
0.32
0.00
-0.31%
DXCM
75.19
-0.72
-0.95%
GNMK
9.49
+0.05
+0.53%
HALO
12.16
+0.06
+0.50%
ILMN
193.62
-1.14
-0.59%
INNV
0.114
-0.003
-2.564%
INO
5.55
-0.01
-0.18%
ISCO
1.2
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
126.88
-1.09
-0.85%
LPTN
2.93
-2.93
-100.00%
MBVX
0.465
-0.045
-8.824%
MEIP
2.44
-0.14
-5.43%
MNOV
5.05
0.00
0.00%
MRTX
5.2
-0.1
-1.89%
MSTX
0.13
-0.01
-5.28%
NBIX
51.98
-0.68
-1.29%
NUVA
63.42
-1.28
-1.98%
ONCS
0.93
-0.01
-1.06%
ONVO
1.88
-0.07
-3.59%
OREX
2.36
+0.02
+0.85%
OTIC
20.3
-0.05
-0.25%
QDEL
33.46
-0.02
-0.06%
RCPT
231.96
0.00
0.00%
RGLS
0.919
+0.059
+6.8256%
RMD
73.91
-0.64
-0.86%
SCIE
0
0.00
0.00%
SPHS
1.91
+0.02
+1.06%
SRNE
1.65
-0.05
-2.94%
TROV
0.83
-0.02
-2.35%
VICL
2.37
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
12.15
-0.3
-2.41%
ACAD
31.91
+0.47
+1.49%
AEMD
1.5
+0.08
+5.6268%
APRI
1.514
+0.034
+2.2838%
ARNA
20.75
-0.27
-1.28%
ATEC
1.94
+0.02
+1.04%
CNAT
5.12
-0.06
-1.16%
CRXM
0.172
0.00
0.00%
CYTX
0.32
0.00
-0.31%
DXCM
75.19
-0.72
-0.95%
GNMK
9.49
+0.05
+0.53%
HALO
12.16
+0.06
+0.50%
ILMN
193.62
-1.14
-0.59%
INNV
0.114
-0.003
-2.564%
INO
5.55
-0.01
-0.18%
ISCO
1.2
0.00
0.00%
ISIS
57.56
0.00
0.00%
LGND
126.88
-1.09
-0.85%
LPTN
2.93
-2.93
-100.00%
MBVX
0.465
-0.045
-8.824%
MEIP
2.44
-0.14
-5.43%
MNOV
5.05
0.00
0.00%
MRTX
5.2
-0.1
-1.89%
MSTX
0.13
-0.01
-5.28%
NBIX
51.98
-0.68
-1.29%
NUVA
63.42
-1.28
-1.98%
ONCS
0.93
-0.01
-1.06%
ONVO
1.88
-0.07
-3.59%
OREX
2.36
+0.02
+0.85%
OTIC
20.3
-0.05
-0.25%
QDEL
33.46
-0.02
-0.06%
RCPT
231.96
0.00
0.00%
RGLS
0.919
+0.059
+6.8256%
RMD
73.91
-0.64
-0.86%
SCIE
0
0.00
0.00%
SPHS
1.91
+0.02
+1.06%
SRNE
1.65
-0.05
-2.94%
TROV
0.83
-0.02
-2.35%
VICL
2.37
0.00
0.00%
VOLC
18
0.00
0.00%
ZGNX
12.15
-0.3
-2.41%
Home » Archive by Category

Xconomy

Request Your Invitation to Xconomy’s Elite Napa Summit June 8-9

April 20, 2017 – 8:23 pm

  Nobel Laureate David Baltimore. Microbiome AND supercomputer pioneer Larry Smarr. Intellectual Ventures’ Nathan Myhrvold. Nicole Glaros of Techstars. These are just a few of the visionary…

[[Click headline to continue reading.]]

Phoenix Shops Its Cancer Drug as Potential Alzheimer’s Treatment

April 20, 2017 – 3:00 am

San Antonio — George Perry, a scientist at the University of Texas at San Antonio, has long proposed that drug developers and researchers need to look earlier into the roots of Alzheimer’s…

[[Click headline to continue reading.]]

“Our Son’s Fate”: Parents Fighting for Kids’ Spine Drug Eye New Data

April 20, 2017 – 2:53 am

Melissa Marotta pulled no punches to get her three-year-old son C.J., who has the genetic disease spinal muscular atrophy, access to nusinersen (Spinraza), the first approved drug for his condition….

[[Click headline to continue reading.]]

Want to Communicate Your Science? First, Step Back

April 19, 2017 – 1:55 am

Think for a moment about the words and phrases that life science researchers and executives use on a daily basis. I’m talking about the seemingly simple phrases like “investigational drug,” “novel…

[[Click headline to continue reading.]]

Bio Roundup: CRISPR Appeal, Bristol Deals, Stock Pumping & More

April 14, 2017 – 2:00 am

It may have been a short holiday week, but there was plenty of news on the CRISPR front. In the ongoing battle for rights to the landmark gene editing technology, the faction led by the University of…

[[Click headline to continue reading.]]

Tocagen IPO Raises $85M to Test Gene Therapy in Brain Cancer Trials

April 13, 2017 – 9:45 am

Tocagen raised $85 million in its stock market debut today, and underwriters saw enough demand to increase the number of shares in the initial public offering. Tocagen has been developing a gene…

[[Click headline to continue reading.]]

The Human Impact of Machine Learning in Medical Diagnostics & More

April 12, 2017 – 9:40 pm

In January, UC San Diego announced that a group of scientists had succeeded in training a computer to tell the difference between a person with a “healthy” intestine from someone with inflammatory…

[[Click headline to continue reading.]]

Cirius Therapeutics Raises $40M to Expand Ongoing Liver Study

April 11, 2017 – 4:00 am

A $40 million transfusion led by Frazier Healthcare Partners and Denmark’s Novo A/S is bringing fresh life to a Michigan biotech working to advance a new experimental drug for treating a type of…

[[Click headline to continue reading.]]

Bio Roundup: Gottlieb Talks Vax, Acorda’s Axe, Adams, 23andMe & More

April 7, 2017 – 2:32 am

In the nation’s capital, healthcare and life sciences were on center stage. Or stages, actually. On Capitol Hill, FDA commissioner nominee Scott Gottlieb, the drug industry’s favorite…

[[Click headline to continue reading.]]

FDA OKs 23andMe’s Direct-to-Consumer Genetic Tests, With Caution

April 6, 2017 – 1:34 pm

[Updated 4/6/17, 7:42 pm. See below.] Consumers who aren’t squeamish about spitting into a tube and sending it to a lab can now have 23andMe test those samples to assess their risk of developing…

[[Click headline to continue reading.]]